Tag: Pricing
Business & Industry
Australia Reviews PBS Pricing Framework Amid Industry Dispute Over Benchmarks
The Australian government is currently navigating a significant period of reassessment regarding its national drug reimbursement model, as tensions between global pharmaceutical manufacturers and...
Business & Industry
Germany to Double Mandatory Drug Rebates to 15.5 Percent
As European nations seek to stabilize their national health systems, the resulting regulatory changes are prompting a reassessment of market priority and supply chain...
Business & Industry
AstraZeneca UK Investment Resumes with £300m Commitment
In a reversal of its earlier stance, AstraZeneca has confirmed a £300m commitment to the UK, marking a renewed push into domestic operations after...
Business & Industry
Trump Announces 100% US Pharma Tariffs for Patented Drugs
The US pharma tariffs policy has been formalised through an executive order signed by Donald Trump, introducing tariffs of up to 100% on imported...
Business & Industry
CMS Extends GENEROUS MFN Drug Pricing Deadline to April
The Centers for Medicare & Medicaid Services (CMS) in the US has moved to extend the enrolment window for its GENEROUS pilot programme, an...
Business & Industry
CMS Unveils a New Voluntary Access Programme For GLP-1
In the most recent of a string of announcements ahead of the holiday season, Centers for Medicare & Medicaid Services (CMS) has unveiled a new...
Business & Industry
Novartis to Lower Innovative Medicines Price in the US
Novartis, which is a leading global innovative medicines company, went ahead and announced on December 19, 2025, that it has reached an agreement along with...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read